Electromed, Inc. 10-Q

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. On September 11, 2024, we announced the approval of a stock repurchase authorization. Under the authorization, the Company could repurchase up to $5,000,000 shares of common stock. A total of 280,017 shares were repurchased and retired under this authorization for a total cost of $5,000,000, or $17.86 per share. This repurchase authorization has been exhausted in its entirety. On March 6, 2025, we announced the approval of a new stock repurchase authorization. Under the new authorization, the Company may repurchase up to $5,000,000 shares of common stock. This repurchase authorization has no expiration date. Through March 31, 2025, a total of 60,036 shares were repurchased and retired for a total cost of $1,449,000, or $24.14 per share. Under this authorization, shares of our common stock may be repurchased on the open market or in privately negotiated transactions subject to applicable securities laws and regulations. As of March 31, 2025, approximately $3,551,000 shares of common stock remained available for repurchase. The following table sets forth information concerning all repurchases of shares of our common stock for the three months ended March 31, 2025: Total Number of Approximate Dollar Shares Purchased Value of Shares that as Part of Publicly May Yet be Purchased Total Number of Average Price Announced Plans Under the Plans Period Shares Purchased Paid per Share or Programs or Programs January 1 – January 31, 2025 - $ - - $ 464,000 February 1 – February 28, 2025 17,076 $ 26.86 17,076 $ 5,000 March 1 – March 31, 2025 60,221 $ 24.15 60,221 $ 3,551,000 Total 77,297 77,297 Item 3. Defaults Upon Senior Securities. None. Item 4. Mine Safety Disclosures. None.